MichaelHutchinsonMD

PubMed

• 7536 citations
  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
  Chris H. Polman, Stephen C. Reingold, Brenda Banwell, Michel Clanet, Jeffrey A. Cohen
  Annals of Neurology. 2011-02-01
• 33 citations
  Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel
  J. Theodore Phillips, Michael Hutchinson, Robert J. Fox, Ralf Gold, Eva Havrdova
  Multiple Sclerosis and Related Disorders. 2014-07-01
• 1002 citations
  Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
  Robert J. Fox, David Miller, J. Theodore Phillips, Michael Hutchinson, Eva Havrdova
  The New England Journal of Medicine. 2012-09-19

Journal Articles

• Do patients with mild traumatic brain injury have more lesions on their MRI scans?  
  Hutchinson M, Mag. Reson. Imaging, 1/1/2018
• Is the fastest MRI a hologram?  
  Hutchinson M and Raff U, J. Neuroimaging, 1/1/2014
• Gene therapy for Parkinson Disease: where do we stand?  
  Hutchinson M, Journal Watch Neurology, 1/1/2011
• Self-referral of imaging does not imply overutilization  
  Hutchinson M, Chawluk JB, Gomez C, Greenberg J, Hussey F, Preston WG, and Zimmerman E, J. Neuroimaging, 1/1/2009
• On the toxicity of GDNF  
  Hutchinson M, Toxicologic Pathology, 1/1/2008
• Neuroimaging of movement disorders  
  Hutchinson M, Neurology Continuum, 1/1/2008
• Detection of Parkinson's Disease by MRI: Spin-Lattice Distribution Imaging  
  Hutchinson M and Raff U, Movement Disorders, 1/1/2008
• On false negatives in MRI studies of Parkinson's Disease  
  Hutchinson M and Raff U, Movement Disorders, 1/1/2007
• Image fusion in neuroradiology: three clinical examples including MRI of Parkinson's Disease  
  Rojas GM, Raff U, Quintana JC, Huete I, Hutchinson M, Computerized Medical Imaging and Graphics, 1/1/2007
• Chaos theory and the treatment of refractory status epilepticus: who benefits from prolonged anesthesia, and is there a better way?  
  Hutchinson M and Swanson PD, Medical Hypotheses, 1/1/2007
• GDNF in Parkinson Disease: an object lesson in the tyranny of Type II  
  Hutchinson M, Gurney S, Newson R, J. Neuroscience Methods, 1/1/2007
• GDNF in the treatment of Parkinson's Disease: response to editorial  
  Penn R, Dalvi A, Slevin J, Young B, Gash D, Gerhardt G, Hutchinson M, Lancet Neurology, 1/1/2006
• Inversion recovery MRI in idiopathic Parkinson's Disease is a sensitive tool to assess neurodegeneration in the substantia nigra  
  Raff U, Hutchinson M, Rojas GM, Huete I, Academic Radiology, 1/1/2006
• On the use of clusters to determine environmental influence on disease  
  Hutchinson M and Lebedev S, Arch. Neurol., 1/1/2005
• Genetic Basis of Common Diseases: General Theory of Mendelian Recessive Genetics  
  Hutchinson M, Spanaki C, Lebedev S, Plaitakis A, Medical Hypotheses, 1/1/2005
• Bilateral intraputaminal infusion of liatermin (GDNF) in subjects with advanced Parkinson's Disease  
  Gill S, Heywood P, Lozano AM, Lang A, Moro E, Penn R, Dalvi A, Burchiel KJ, Nutt J, Kelly P, Hutchinson M, et al, Neurosurgery, 1/1/2004
• Computer assessment of neurodegeneration in Parkinson's Disease using data fusion techniques with MR images  
  Raff U, Rojas GM, Huete I and Hutchinson M, Acad. Radiol., 1/1/2003
• Cognitive, psychiatric and motor responses to galantamine in Parkinson's Disease with dementia  
  Aarsland D, Hutchinson M and Larsen JP, Int. J. Geriatric Psych., 1/1/2003
• "Galantamine for Parkinson's Disease with dementia"  
  Aarsland A and Hutchinson M, J. Clin. Psych., 1/1/2002
• "The use of MRI in diagnosing Parkinson's Disease and differentiating it from Progressive Supranuclear Palsy"  
  Hutchinson M and Raff U, Neurology, 1/1/2001
• Structural changes of the substantia nigra in Parkinson's disease, as revealed by MR imaging  
  Hutchinson M and Raff U, Am. J. Neuroradiology, 1/1/2000
• Quantitation of T2 lesion load in multiple sclerosis: a novel semi-automated MR segmentation technique  
  Raff U, Rojas GM, Hutchinson M and Simon JH, Acad Radiol, 1/1/2000
• Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra  
  Hutchinson M and Raff U, J. Neurol. Neurosurg. Psychiatry, 1/1/1999
• "MRI reveals structural changes in the substantia nigra in Parkinson's disease"  
  Hutchinson M and Raff U, Neurology, 1/1/1999
• Task specific deactivations in functional magnetic resonance imaging (fMRI)  
  Hutchinson M, Schiffer W, Joseffer S, Liu A, Schlosser R, Goldberg E, Brodie JD, Mag. Res. Imaging, 1/1/1999
• Join now to see all

Books/Book Chapters

• Vascular Malformations of the Central Nervous System 
  Chapter: "Diagnostic Evaluation: Functional Imaging" 
  Page 209 - 216Hutchinson MEditors: Jafar JJ, Awad IA, Rosenwasser RH.Lipincott, Williams & Wilkins, Philadelphia1999
• Neurological Surgery 
  Chapter: Neurosurgical applications of Positron Emission Tomography. 
  Page 172 - 184Hutchinson M, Nenov V, and Mazziotta JCEditors: Youmans, J.Saunders, PhiladelphiaEdition 4th,1996
• Laser-Controlled Chemical Processing of Surfaces 
  Chapter: Theoretical Aspects of Laser-Induced Periodic Surface Structure Formation 
  Hutchinson M, Lee KT, Murphy WC, Beri AC and George TFEditors: AW Johnson and DJ Ehrlich.Elsevier, New York1984
• Advances in Multiphoton Processes and Spectroscopy 
  Chapter: Laser-induced molecular dynamics: rate processes in the gas phase and at solid surfaces. 
  Lin JT, Hutchinson M and George TFEditors: SH Lin.World Scientific, Singapore1984
• Advances in Laser Spectroscopy 
  Chapter: Laser-Induced Bound-Continuum Interactions 
  George TF, Lam KS, Hutchinson M and Murphy WCEditors: BA Garetz and JR Lombardi.Wiley, New York1983
• Theory of Chemical Reaction 
  Chapter: Theory of Reactions at Solid Surfaces 
  George TF, Lee KT, Murphy WC, Hutchinson M and Lee HWEditors: M Baer.CRC Press, Boca Raton, FL1983
• Photon Assisted Collisions and Related Topics 
  Chapter: Transition State Spectroscopy and Line-Broadening. 
  George TF, Lam KS, Bhattacharyya DK and Hutchinson MEditors: NK Rahman and C Guidotti.Gordon and Breach, Paris, New York1982
• Join now to see all

Abstracts/Posters

• "On the Nature of the Signal Change in Functional MRI"
  Hutchinson M and Nenov V, Abstracts of the Society for Neuroscience 23rd Annual Meeting, 1/1/1993
• "Generalized Fano Model for Laser-Induced Deposition of Molecules"
  Hutchinson M, Huang XY, Liu KC, Lee KT and George TF, 1984 Meeting of the Materials Research Society Society, Boston, MA, 1/1/1984
• Microscopic Theory of Laser-Induced Periodic Surface Structure Formation.
  Beri AC, Murphy, Lee KT, Hutchinson M and George TF, 1983 Meeting of the Materials Research Society, Boston, MA, 1/1/1983
• "Molecular Collisions in a Laser Field: Line-Broadening and Spectroscopy"
  Bhattacharyya DK, DeVries PL, George TF, Hutchinson M and Lam KS, 11th Northeast Regional Meeting of the American Chemical Society, Rochester, NY, 1/1/1981
• Join now to see all

Lectures

• Navigating Your Career: Neuroimaging. 
  Los Angeles, CA - 1/25/2018
• Neuroimaging of Neurodegeneration. 
  Phoenix, AZ - 1/17/2015
• MRI in Parkinson's Disease. 
  Sarasota, FL - 1/19/2014
• MRI biomarker for Parkinson's Disease, and the prospect for a cure. 
  1/10/2010
• The Ferment in Neuroimaging. 
  Salt Lake City - 1/21/2008
• Neuroimaging of Dementia. 
  Boston - 1/5/2007
• Ethical issues in the interruption of a clinical trial for Parkinson's Disease. 
  1/25/2005
• Functional MRI. 
  1/18/2005
• MRI in Neurodegenerative Diseases. 
  North Miami Beach - 1/16/2005
• MRI as a biomarker for Alzheimer's Disease. 
  Naples, FL - 1/7/2005
• Neuroimaging of Movement Disorders. 
  Orlando, FL - 1/5/2005
• Parallel MRI. 
  Orlando, FL - 1/4/2005
• MRI as a biomarker for Parkinson's Disease. 
  San Francisco - 1/2/2004
• Intraputamenal infusion of GDNF for Parkinson's Disease. 
  Chicago - 1/24/2002
• Differential efficacy of cholinesterase inhibitors in Parkinson Dementia, and the relevance this has for Alzheimer's Disease. 
  Thessalonika, Greece - 1/18/2002
• Parkinson's Disease: new developments in imaging, and the prospects for a cure. 
  1/12/2002
• New developments in the treatment of Parkinson dementia. 
  Manhattan - 1/9/2002
• Cholinesterase Inhibitors in Parkinson's Disease. 
  Montreal, Canada - 1/12/2001
• A Look back at early Parallel MRI proposals. 
  Wuerzburg, Germany - 1/8/2001
• MRI reveals structural changes in the substantia nigra in Parkinson's Disease. 
  Toronto - 1/20/1999
• Diagnosis and management issues in early Parkinson's disease. 
  New York - 1/17/1999
• Pharmacolgical management of Parkinson's disease. 
  1/5/1999
• Cholinesterase inhibition in Parkinson's Disease. 
  UK - 1/27/1997
• Join now to see all

Other

• Sub-second MRI Data Acquisition Using Multiple Detectors. 
  Hutchinson M and Raff U, Proceedings, Society for Magnetic Resonance in Medicine, 6th Annual Meeting August 17th 1987, Volume
  New York - 1/1/1987
• "On Laser-Induced Desorption of Molecules from Surfaces" 
  Hutchinson M and George TF, Bulletin of the American Physical Society
  1/1/1985